EPIC Program Annual Data Tables 2006-2007: Table VIII

Table VIII
Twenty Most Frequently Purchased Drugs*
Rank by Number
of Claims
Drug and StrengthDrug
Type**
Number
of Claims
EPIC
Payments
Rank by
Payment
Top 20 Totals2,516,022 $167,269,707
Percent of Top 20 Drugs to Total Paid Claims 22.38% 24.94%
1PLAVIX (75 MG)SS290,161$37,575,2421
2TOPROL XL (50 MG)BNMS204,216$5,888,52420
3NORVASC (5 MG)BNMS165,142$9,377,2328
4FUROSEMIDE (40 MG)Gen157,384$515,224243
5LIPITOR (10 MG)SS147,932$12,864,7856
6TOPROL XL (100 MG)BNMS131,133$5,943,60519
7FOSAMAX (70 MG)SS129,090$10,160,6197
8NORVASC (10 MG)BNMS127,459$9,189,3079
9HYDROCHLOROTHIAZIDE (25 MG)Gen116,690$294,915398
10METOPROLOL TARTRATE (50 MG)Gen107,960$350,461346
11FUROSEMIDE (20 MG)Gen107,295$315,829369
12LIPITOR (20 MG)SS107,017$13,520,5825
13NEXIUM (40 MG)SS106,826$18,736,0042
14PROTONIX (40 MG)SS103,978$13,848,9214
15ATENOLOL (50 MG)Gen91,731$414,201296
16METFORMIN HCL (500 MG)Gen91,524$1,110,541128
17AMBIEN (10 MG)BNMS86,389$6,427,42116
18OMEPRAZOLE (20 MG)Gen83,110$6,853,50214
19ACTONEL (35 MG)SS80,734$6,198,49718
20ZETIA (10 MG)SS80,251$7,684,29512

* Table VIII lists the top 20 drugs ranked by number of adjudicated claims for the program year (October 1, 2006-September 30, 2007) as well as the percentage of the totals they represent for the year.

** Drug Type values are BNMS='Brand Name Multi-Source', Gen='Generic and SS='Sole Source'.